Twitxy Saved

Joan Palou Redorta

@joanfundi

Former Chairman of Urology Dep. Urological Oncology and Robotics. @FPuigvert. Former Chair of ESU. @uab. Friends and Nature.
Barcelona, España fundacio-puigvert.es Joined April 2013
85 Following 4K Followers 3K Posts

Latest posts 5

Joan Palou Redorta @joanfundi
Excellent job present and future!!
Mario I Fernandez Verified account @marigfern Oct 29
Incredibly proud of our team and this recognition! 🏆

A collaborative effort between Clínica Alemana–UDD @UDD_FM @Clinicaalemana , Hospital Regional de Antofagasta @HospitalAntof , and UNC Lineberger @UNC_Lineberger to better understand arsenic-associated bladder cancer.

Our ultimate goal goes beyond scientific recognition: translating discoveries into better care and improved outcomes for patients in Antofagasta, Chile.

Let's work together to make research matter to patients!
@BladderCancerUS @WorldBladderCan @IBCG_BladderCA @CAU_URO @Urolchi @LoebStacy @spsutkaMD @shilpaonc @UroDocAsh
View quoted post on X
Joan Palou Redorta @joanfundi
Congratulations!!
Sia Daneshmand, M.D. Verified account @siadaneshmand Oct 23
It’s with mixed emotions and deep gratitude that I will be leaving USC after 17 years to begin a new exciting chapter @UclaUrology as Director of the Institute of Urologic Oncology and Division Chief of Urologic Oncology. Forever thankful for the trainees, colleagues and patients who have shaped my journey. Grateful to @uroegg and @UCLAHealth leadership for their confidence and vision, and excited to build on their remarkable legacy of excellence.
View quoted post on X
Joan Palou Redorta @joanfundi
No difference in recurrence: TURBT vs EBTUR. Only better substaging (cT1).
Mark Tyson @MarkTysonMD Aug 6
More data on en bloc TURBT showing no difference in long-term #bladdercancer outcomes. Reminds me of the robot for cystectomy. I like it. I do it. But to say it makes things that much better for patients is a probably a bit of a stretch. pubmed.ncbi.nlm.nih.gov/42542426/
View quoted post on X
0 replies 1 reposts 4 likes 1.3K views View on X
Joan Palou Redorta @joanfundi
What does it mean honest discussion? MTD, meeting different experts, expectations, quality of life…unbiased information!!
Ashish M. Kamat, MD, MBBS Verified account @UroDocAsh Jul 28
Excellent editorial highlighting a critical point: cCR is a biomarker, not an endpoint.

This will be a featured topic at this year’s @BladderCancerUS Think Tank. We owe it to our patients to maintain equipoise when discussing the pros and cons of bladder sparing.

That means an honest discussion of cystectomy, radiation, radical TUR, and continued cystoscopies with intravesical therapies as needed @JoshMeeks @koshkin85 @SimaPorten @DrRosenbergMSK @shilpaonc @AndreaNecchi @MattGalsky @IBCG_BladderCA @EUplatinum @AlisonBirtle
View quoted post on X